Epilepsy Clinical Trials in Phoenix

Showing 1-20 of 96 trials

Safety and Efficacy of tPBM for Epileptiform Activity in Autism

NCT06352372

For this study, the proposed intervention will be noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM) - to the brains of autistic children with abnormal EEGs with epileptiform discharges or with epilepsy. This will occur, twice a week, for 10 weeks. The NIR light is delivered to specific brain areas by Cognilum, a wearable device developed by Jelikalite. The expected outcome is improved focus, improved eye contact, improved speech, improved behavior, and gains in functional skills. Cognilum may impact the clinical practice of treating autism. At the beginning, at five weeks, and at the end of study, the clinician will complete the CARS-2, SRS, CGI, and a caregiver interview; additionally, questionnaires will be administered to caregivers during one of the 1-hour weekly treatment sessions.

Autism Spectrum DisorderEEG With Periodic AbnormalitiesEpilepsy+2 more

Richard Frye6 participantsStarted Jul 2024

Phoenix, Arizona, United States

Enrolling By InvitationPhase 3< 1 mile

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

NCT05076617

The purpose of the study is to evaluate the long-term safety and tolerability of Staccato alprazolam.

Stereotypical Prolonged Seizures

UCB Biopharma SRL300 participantsStarted Feb 2022

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +143 more locations

Safety and Efficacy of tPBM for Epileptiform Activity in Autism

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Epilepsy Trials in Other Cities

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Electrochemical and Electrophysiological Study

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

Pediatric Dose Optimization for Seizures in Emergency Medical Services

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Epilepsy Adherence in Children and Technology (eACT)

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

STXBP1 and SYNGAP1 Related Disorders Natural History Study

RNS System LGS Feasibility Study

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Other Conditions in Phoenix